Darragh McArt

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Neoplasms 54%
3. Biomarkers 47%
4. Breast Neoplasms 39%
5. Gene Expression 28%
6. Genes 24%
7. Survival 23%
8. Immunohistochemistry 22%
9. Adjuvant Chemotherapy 21%
10. Therapeutics 20%
11. Colonic Neoplasms 17%
12. Caspase 8 16%
13. Comet Assay 16%
14. Neoplasm Genes 15%
15. Molecular Pathology 15%
16. RNA-Seq 14%
17. Mutation 14%
18. human ERBB2 protein 14%
19. Software 13%
20. Prostatic Neoplasms 13%
21. GTP Phosphohydrolases 13%
22. Rectal Neoplasms 12%
23. Tumor Biomarkers 11%
24. Northern Ireland 11%
25. Transcriptome 11%
26. Drug Therapy 11%
27. Cystatin M 11%
28. TNF-Related Apoptosis-Inducing Ligand Receptors 10%
29. Receptor Protein-Tyrosine Kinases 10%
30. Ovarian Neoplasms 10%
31. Biopsy 10%
32. RNA Sequence Analysis 10%
33. Non-Small Cell Lung Carcinoma 10%
34. Adenocarcinoma 10%
35. High-Throughput Nucleotide Sequencing 10%
36. Chemoradiotherapy 9%
37. Atlases 9%
38. asparaginylendopeptidase 9%
39. DNA Damage 9%
40. Triple Negative Breast Neoplasms 9%
41. cathepsin S 8%
42. Technology 8%
43. Fluorouracil 8%
44. Biomedical Research 8%
45. Recurrence 8%
46. Precision Medicine 8%